Dikici Serkan
Department of Bioengineering, Faculty of Engineering, Izmir Institute of Technology, İzmir, Turkey.
Turk J Biol. 2021 Nov 2;46(1):41-56. doi: 10.3906/biy-2108-27. eCollection 2022.
The selection of a wound dressing is crucial for successful wound management. Conventional dressings are preferable for the treatment of simple wounds. However, a bioactive wound dressing that supports wound management and accelerates the healing process is required when it comes to treating non-self-healing wounds. 2-deoxy-D-ribose (2dDR) is a small deoxy sugar that naturally occurs in human body. Although we have previously demonstrated that 2dDR can be used to induce neovascularisation and accelerates wound healing in vitro and in vivo, the literature on small sugars is conflicting, and the knowledge on how 2dDR achieves its biological activity is very limited. In this study, several small sugars including D-glucose (DG), 2-deoxy-D-glucose (2dDG), 2deoxy-L-ribose (2dLR) were compared to 2dDR by investigating their effects on the metabolic activities of both human dermal microvascular endothelial cells (HDMECs) and human dermal fibroblasts (HDFs). Then, for the first time, a two-dimensional (2D) scratch wound healing model was used to explore the migratory response of HDFs in response to 2dDR treatment. Finally, 2dDR was incorporated into Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) polymer fibres via electrospinning, and the metabolic activity of both types of cells in vitro was investigated in response to sugar release via Alamar Blue assay. The results demonstrated that 2dDR was the only sugar, among others, that enhances the metabolic activity of both HDMECs and HDFs and the migratory response of HDFs in a 2D scratch assay in a dose-dependent manner. In addition to direct administration, 2dDR was also found to increase the metabolic activity of HDMECs and HDFs over 7 days when released from polymer fibres. It is concluded that 2dDR is a potential pro-angiogenic agent that has a positive impact not only on endothelial cells but also fibroblasts, which take a key role in wound healing. It could easily be introduced into polymeric scaffolds to be released quickly to enhance the metabolic activity and the migratory response of cells that are associated with angiogenesis and wound healing.
伤口敷料的选择对于伤口的成功处理至关重要。传统敷料更适合用于治疗简单伤口。然而,在治疗无法自愈的伤口时,需要一种能够支持伤口处理并加速愈合过程的生物活性伤口敷料。2-脱氧-D-核糖(2dDR)是一种天然存在于人体中的小脱氧糖。尽管我们之前已经证明2dDR可用于诱导新血管形成并在体外和体内加速伤口愈合,但关于小糖的文献存在矛盾之处,而且关于2dDR如何实现其生物活性的知识非常有限。在本研究中,通过研究几种小糖包括D-葡萄糖(DG)、2-脱氧-D-葡萄糖(2dDG)、2-脱氧-L-核糖(2dLR)对人真皮微血管内皮细胞(HDMECs)和人真皮成纤维细胞(HDFs)代谢活性的影响,将它们与2dDR进行了比较。然后,首次使用二维(2D)划痕伤口愈合模型来探究HDFs对2dDR处理的迁移反应。最后,通过静电纺丝将2dDR掺入聚(3-羟基丁酸酯-co-3-羟基戊酸酯)(PHBV)聚合物纤维中,并通过阿拉玛蓝测定法研究体外两种类型细胞对糖释放的代谢活性。结果表明,2dDR是唯一一种能以剂量依赖方式增强HDMECs和HDFs的代谢活性以及HDFs在2D划痕试验中的迁移反应的糖。除了直接给药外,还发现当2dDR从聚合物纤维中释放时,在7天内也能增加HDMECs和HDFs的代谢活性。结论是,2dDR是一种潜在的促血管生成剂,不仅对内皮细胞有积极影响,对在伤口愈合中起关键作用的成纤维细胞也有积极影响。它可以很容易地引入聚合物支架中快速释放,以增强与血管生成和伤口愈合相关的细胞的代谢活性和迁移反应。